Is Bio-Rad Laboratories, Inc. overvalued?

Bio-Rad Laboratories, Inc. (BIO) looks overvalued — trading about 54% above its fair value.

Overvalued

Price

$358.42

Fair value

$166.46

Current P/E

38.7

Normal P/E

18.0

Market cap

$9.65B

Dividend yield

0.0%

Return on equity

3.2%

Sector

Healthcare

Fair value compares BIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks